Drugs / Lactiplantibacillus plantarum Probio87
Lactiplantibacillus plantarum Probio87
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05316064 | Dec 2021 → Nov 2023 | human papilloma virus infection | Universiti Sains Malaysia | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactiplantibacillus plantarum Probio87 | “a probiotic Lactiplantibacillus plantarum Probio87 (orally administered at 9 log CFU/day) or placebo for 12-weeks, on reducing the abundance of vaginal HPV in HPV-positive women.” PMID 40360161 ↗ May 2025 |
| Action | Inhibit | “to reduce vaginal abundance of HPV in women compared to placebo” NCT05316064 ↗ |
| Modality | Other / unclassified | “a probiotic Lactiplantibacillus plantarum Probio87” PMID 40360161 ↗ May 2025 |
| Route | Oral | “orally administered at 9 log CFU/day” PMID 40360161 ↗ May 2025 |